Daniel Ryweck

Daniel Ryweck

Director of Finance/CFO at SILO PHARMA, INC.

Net worth: 2 068 $ as of 30/06/2026

62 year
Health Technology
Finance
Consumer Services

Profile

Mr. Daniel E.
Ryweck
is a Chief Financial Officer at Silo Pharma, Inc. Mr. Ryweck was previously employed as a Chief Financial Officer by Sun BioPharma, Inc. and a Controller by SUI Group Holdings Ltd. He also served on the board at Dala Petroleum Corp.
and KonaTel, Inc. He received his undergraduate degree from The Curtis L.
Carlson School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/08/2025 333 ( 0.03% ) 2 068 $ 30/06/2026

Daniel Ryweck active positions

CompaniesPositionStart
SILO PHARMA, INC. Director of Finance/CFO 27/09/2022

Former positions of Daniel Ryweck

CompaniesPositionEnd
Director/Board Member 31/08/2017
KONATEL, INC. Director/Board Member 31/08/2017
SUN BIOPHARMA INC Director of Finance/CFO 01/09/2015
SUI GROUP HOLDINGS LIMITED Compliance Officer 31/12/2019
See the detail of Daniel Ryweck's experience

Training of Daniel Ryweck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

21

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Finance

Health Technology

Consumer Services

Energy Minerals

Health Technology

Communications